nrneph.2013.110-pf1

Sep 20, 2014

20 likes | 159 Views

Figure 1 Mechanisms by which aldosterone and/or MR activation induce oxidative stress, inflammation, and fibrosis. Brown, N. J. (2013) Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis Nat. Rev. Nephrol. doi:10.1038/nrneph.2013.110.

Share Presentation

Embed Code

Link

inflammation
renal inflammation
fibrosis nat
2013 contribution
doi 10
figure 1 mechanisms

wirt

Download Presentation

nrneph.2013.110-pf1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Figure 1 Mechanisms by which aldosterone and/or MR activation induce oxidative stress, inflammation, and fibrosis Brown, N. J. (2013) Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis Nat. Rev. Nephrol. doi:10.1038/nrneph.2013.110

nrneph

Figure 2 Features of subclinical or indolent ABMR, which is typically diagnosed in protocol biopsies performed at 3 months or 1 year after transplantation in kidney transplant recipients who have preformed DSAs and are receiving potent immunosuppressive conditioning.

144 views • 1 slides

nrneph.2013.22-pt1

Table 1 Studies in rats showing the involvement of vasopressin and V2Rs in CKDs, albuminuria and hypertension. Bankir, L. et al. (2013) Vasopressin: a novel target for the prevention and retardation of kidney disease? Nat. Rev. Nephrol. doi:10.1038/nrneph.2013.22.

163 views • 1 slides

nrneph.2014.91-pf3

Figure 3 TLRs, NLRs and the NLRP3 inflammasome drive host defence and tissue repair mechanisms by the clearance of pathogens and cell debris and by regulation of repair pathways. Leemans, J. C. et al. (2014) Pattern recognition receptors and the inflammasome in kidney disease

138 views • 1 slides

ncponc1183-pf1

Figure 1 Radiographic changes to melanoma metastases in the brain with administration of CTLA-4 blockade. Hodi FS et al . (2008) CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS Nat Clin Pract Oncol doi:10.1038/ncponc1183.

131 views • 1 slides

nrendo.2010.146-pf1

Figure 1 World map indicating developing countries as classified by World Bank criteria in color and relating latitude by geographic regions to skin ability to synthesize vitamin D as estimated from information provided in an article by Tavera-Mendoza and White.

123 views • 1 slides

nrneph.2012.196-pf3

Figure 3 Comparison of a mild case and severe case of STEC-HUS treated at the University Hospital in Hamburg–Eppendorf during the German outbreak in 2011. Trachtman, H. et al . (2012) Renal and neurological involvement in typical Shiga toxin-associated HUS

155 views • 1 slides

ncponc0379-pf1

Figure 1 Whole-body positron emission tomography scan showing a small glucose-avid lesion in the pelvis just superior to the bladder in the region of the left adnexa. Santillan A and Bristow RE (2006) Paraneoplastic cerebellar degeneration in a woman with ovarian cancer

123 views • 1 slides

nrneph.2009.67-pf1

Figure 1 Renal survival of patients in our study with pauci-immune crescentic glomerulonephritis with and without ANCAs. Permission obtained from the American Society of Nephrology  Chen, M. et al. Antineutrophil cytoplasmic autoantibody negative pauci-immune crescentic glomerulonephritis.

143 views • 1 slides

ncponc0294-pf1

Figure 1 CT scan of tumor progression showing enlarged right laterocervical lymph nodes (white arrows) and laryngeal tumor (black arrows). Ares C and Allal AS (2005) Long-term complete remission of laryngeal Kaposi's sarcoma after palliative

148 views • 1 slides

ncponc0044-pf1

Figure 1 The products of two genes are required to reconstitute basic telomerase activity; the RNA component, hTR, which includes the template for synthesis of telomere DNA, and the protein catalytic component, hTERT, which has reverse transcriptase activity.

153 views • 1 slides

ncpgasthep0096-pf1

FIGURE 1 Localization of potential relevant molecular targets in irritable bowel syndrome with the specific classes of agents discussed in this Review. Cremonini F and Talley NJ (2005) Treatments targeting putative mechanisms in irritable bowel syndrome

142 views • 1 slides

ncponc0135-pf1

Figure 1 Postpartum contrast-enhanced helical chest CT scan showing an enlarged internal mammary lymph node (white arrow). Matthew S Katz et al . (2005) Palpable right breast mass in a pregnant woman . Nat Clin Pract Oncol 2 : 218 – 221 10.1038/ncponc0135.

166 views • 1 slides

ncprheum0173-pf1

Figure 1 Minor salivary gland biopsy, stained with hematoxylin-eosin, from a patient with Sj ö gren's syndrome. Nordmark G et al. (2006) Mechanisms of Disease: primary Sj ö gren's syndrome and the type I interferon system Nat Clin Pract Rheumatol 2: 26 2 – 269 doi:10.1038/ ncprheum0173.

228 views • 1 slides

ncponc0813-pf1

Figure 1 Combination treatment schema for patients with rectal cancer enrolled in a clinical trial. Willett CG et al . (2007) Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer Nat Clin Pract Oncol 4 : 316 –321 doi:10.1038/ncponc0813.

146 views • 1 slides

ncponc1156-pf1

Figure 1 Results of cardiac function tests in the phase III trial of lapatinib plus capecitabine for metastatic breast cancer. Permission obtained from Geyer CE et al . (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355: 2733–2743.

114 views • 1 slides

ncponc0736-pf1

Figure 1 Schematic of oncolytic virotherapy mechanism of action: viral replication, cell killing, virus release and spread within cancer tissue but not normal tissues.

139 views • 1 slides

nrneph.2012.214-pt1

Table 1 Evidence supporting the role of complement dysregulation and the benefit of C5 blockade in aHUS and C3G. Zuber, J. et al. (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies Nat. Rev. Nephrol. doi:10.1038/nrneph.2012.214.

158 views • 1 slides

nrneph.2012.214-pt2

Table 2 Clinical and genetic characteristics of 24 off-trial patients treated with eculizumab for overt aHUS. Zuber, J. et al. (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies Nat. Rev. Nephrol. doi:10.1038/nrneph.2012.214.

143 views • 1 slides

ncpneuro0658-pf1

Figure 1 Images of the case patient with an interstitial deletion of 5q22 encompassing the APC (adenomatous polyposis coli) gene, taken at 22 years of age. Heald B et al. (2007) Familial adenomatous polyposis in a patient with unexplained mental retardation

113 views • 1 slides

ncpneph0301-pf1

Figure 1 The principal source of renal dopamine is circulating L -DOPA, which is freely filtered by the glomerulus.

78 views • 1 slides

nrrheum.2014.167 pf1

Figure 1 Infection with JC virus is at first asymptomatic and presumably occurs at an early age by oral route. Calabrese, L. H. et al. (2014) Sorting out the risks in progressive multifocal leukoencephalopathy Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.167.

177 views • 1 slides

nrneph.2012.213 pf2

Figure 2 Activation of C3 convertase is involved in both complement-mediated and immune-complex-mediated MPGN. Bomback, A. S. & Appel, G. B. (2012) Pathogenesis of the C3 glomerulopathies and reclassification of MPGN Nat. Rev. Nephrol. doi:10.1038/nrneph.2012.213.

225 views • 1 slides

More Related